{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-19T23:39:26.765238+00:00","published_at":"2026-10-19T14:45:38.983665+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1v5u71t1cbau9h","event_type":"CEO_CHANGED","effective_at":"2026-03-31","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:person:james-j-martin","alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:fdfb9562896e5a7ab9b95cafab68cf9724e5f874fc44c93dc30d1e71a4284bb5"],"summary":"James J. Martin executive of Cocrystal Pharma, Inc., effective 2026-03-31.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1dtrxro1bcp64w","event_type":"CEO_CHANGED","effective_at":"2026-03-31","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:person:sam-lee","alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:be2bdda64908a25cbf081de8f4ed1c0312a7f849fbfc2c982e006bb4c24964db"],"summary":"Sam Lee executive of Cocrystal Pharma, Inc., effective 2026-03-31.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1et09001ock1do","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:person:fred-hassan","alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Fred Hassan seat on Cocrystal Pharma, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:4r4cwk1pw4ihc","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:person:richard-c-pfenniger-jr","alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Richard C. Pfenniger, Jr. seat on Cocrystal Pharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ei8qia1lcjy64","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:committee:cocrystal-pharma-inc:compensation-chair","alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Compensation · Chair committee of Cocrystal Pharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:fdtwwuft0kg","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:person:richard-c-pfenniger-jr","alpha:committee:cocrystal-pharma-inc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Richard C. Pfenniger, Jr. member of Compensation · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:fgamfm17r16pg","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:person:roger-kornberg","alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Roger Kornberg seat on Cocrystal Pharma, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:wqrepm1otfwou","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:person:anthony-japour","alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Anthony Japour seat on Cocrystal Pharma, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:190f4q2sj0d4u","event_type":"COMMITTEE_CREATED","effective_at":"2019-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:committee:cocrystal-pharma-inc:audit-compensation","alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Audit; Compensation committee of Cocrystal Pharma, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:qqjsusbh283i","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:person:anthony-japour","alpha:committee:cocrystal-pharma-inc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Anthony Japour member of Audit; Compensation, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:a6pycb8mzhit","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:person:phillip-frost","alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Phillip Frost seat on Cocrystal Pharma, Inc., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:3t2f6z1ps9hu7","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:person:steven-rubin","alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Steven Rubin seat on Cocrystal Pharma, Inc., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:9hceqb1il57gn","event_type":"COMMITTEE_CREATED","effective_at":"2014-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:committee:cocrystal-pharma-inc:audit-chair","alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Audit · Chair committee of Cocrystal Pharma, Inc., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1dakw5ufsfsym","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2014-01-01","detected_at":"2026-10-19T14:45:38.983665+00:00","subject_ids":["alpha:person:steven-rubin","alpha:committee:cocrystal-pharma-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3"],"summary":"Steven Rubin member of Audit · Chair, effective 2014-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:5","subject_id":"alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:anthony-japour","object_label":"Anthony Japour","object_source_name_forms":[],"value":"Anthony Japour: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:anthony-japour","name":"Anthony Japour"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:38.983665+00:00","sources":[{"id":"alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cocrystal Pharma, Inc. DEF 14A 2025-05-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225008692/formdef14a.htm","source_date":"2025-05-05","retrieved_at":"2026-04-28T23:23:01.553+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-05","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:38.983665+00:00","reviewed_at":"2026-10-19T14:45:38.983665+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:6","subject_id":"alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:fred-hassan","object_label":"Fred Hassan","object_source_name_forms":[],"value":"Fred Hassan: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:fred-hassan","name":"Fred Hassan"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:38.983665+00:00","sources":[{"id":"alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cocrystal Pharma, Inc. DEF 14A 2025-05-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225008692/formdef14a.htm","source_date":"2025-05-05","retrieved_at":"2026-04-28T23:23:01.553+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-05","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:38.983665+00:00","reviewed_at":"2026-10-19T14:45:38.983665+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:7","subject_id":"alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:phillip-frost","object_label":"Phillip Frost","object_source_name_forms":[],"value":"Phillip Frost: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:phillip-frost","name":"Phillip Frost"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:38.983665+00:00","sources":[{"id":"alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cocrystal Pharma, Inc. DEF 14A 2025-05-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225008692/formdef14a.htm","source_date":"2025-05-05","retrieved_at":"2026-04-28T23:23:01.553+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-05","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:38.983665+00:00","reviewed_at":"2026-10-19T14:45:38.983665+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:8","subject_id":"alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-c-pfenniger-jr","object_label":"Richard C. Pfenniger, Jr.","object_source_name_forms":[],"value":"Richard C. Pfenniger, Jr.: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-c-pfenniger-jr","name":"Richard C. Pfenniger, Jr."},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:38.983665+00:00","sources":[{"id":"alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cocrystal Pharma, Inc. DEF 14A 2025-05-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225008692/formdef14a.htm","source_date":"2025-05-05","retrieved_at":"2026-04-28T23:23:01.553+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-05","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:38.983665+00:00","reviewed_at":"2026-10-19T14:45:38.983665+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:9","subject_id":"alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:roger-kornberg","object_label":"Roger Kornberg","object_source_name_forms":[],"value":"Roger Kornberg: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:roger-kornberg","name":"Roger Kornberg"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:38.983665+00:00","sources":[{"id":"alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cocrystal Pharma, Inc. DEF 14A 2025-05-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225008692/formdef14a.htm","source_date":"2025-05-05","retrieved_at":"2026-04-28T23:23:01.553+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-05","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:38.983665+00:00","reviewed_at":"2026-10-19T14:45:38.983665+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:10","subject_id":"alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:steven-rubin","object_label":"Steven Rubin","object_source_name_forms":[],"value":"Steven Rubin: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:steven-rubin","name":"Steven Rubin"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:38.983665+00:00","sources":[{"id":"alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cocrystal Pharma, Inc. DEF 14A 2025-05-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225008692/formdef14a.htm","source_date":"2025-05-05","retrieved_at":"2026-04-28T23:23:01.553+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-05","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:38.983665+00:00","reviewed_at":"2026-10-19T14:45:38.983665+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:11","subject_id":"alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:james-j-martin","object_label":"James J. Martin","object_source_name_forms":[],"value":"James J. Martin: Co-Chief Executive Officer, Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:james-j-martin","name":"James J. Martin"},"title":"Co-Chief Executive Officer, Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-31","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-31","valid_to":null,"recorded_at":"2026-10-19T14:45:38.983665+00:00","sources":[{"id":"alpha:projection-evidence:document:fdfb9562896e5a7ab9b95cafab68cf9724e5f874fc44c93dc30d1e71a4284bb5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"COCP 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315226013838/form10-k.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T00:51:53.776184+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31T00:00:00+00:00","effective_from":"2026-03-31","effective_until":null,"observed_at":"2026-10-19T14:45:38.983665+00:00","reviewed_at":"2026-10-19T14:45:38.983665+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b:leadership_role:12","subject_id":"alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44b","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:sam-lee","object_label":"Sam Lee","object_source_name_forms":[],"value":"Sam Lee: Co-Chief Executive Officer, President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:sam-lee","name":"Sam Lee"},"title":"Co-Chief Executive Officer, President","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-31","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-31","valid_to":null,"recorded_at":"2026-10-19T14:45:38.983665+00:00","sources":[{"id":"alpha:projection-evidence:document:be2bdda64908a25cbf081de8f4ed1c0312a7f849fbfc2c982e006bb4c24964db","identity_scope":"source_document_reference","source_type":"sec_filing","title":"COCP 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315226013838/form10-k.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T00:51:53.18823+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31T00:00:00+00:00","effective_from":"2026-03-31","effective_until":null,"observed_at":"2026-10-19T14:45:38.983665+00:00","reviewed_at":"2026-10-19T14:45:38.983665+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:c6a2c6e52093d2a8b3bb789be5f0557b43690e1da7ed1d4f13bd842f18b0ace3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cocrystal Pharma, Inc. DEF 14A 2025-05-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225008692/formdef14a.htm","source_date":"2025-05-05","retrieved_at":"2026-04-28T23:23:01.553+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:fdfb9562896e5a7ab9b95cafab68cf9724e5f874fc44c93dc30d1e71a4284bb5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"COCP 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315226013838/form10-k.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T00:51:53.776184+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:be2bdda64908a25cbf081de8f4ed1c0312a7f849fbfc2c982e006bb4c24964db","identity_scope":"source_document_reference","source_type":"sec_filing","title":"COCP 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315226013838/form10-k.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T00:51:53.18823+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.835,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.863,"cross_source_agreement":0.75,"temporal_completeness":0.615},"diagnostics":{"published_claims":19,"factual_claims":19,"claims_with_linked_evidence":19,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":13,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-19T14:45:38.983665+00:00","observed_at":"2026-10-19T14:45:38.983665+00:00","reviewed_at":"2026-10-19T14:45:38.983665+00:00","verified_at":"2026-10-19T14:45:38.983665+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":19,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/cocrystal-pharma-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/cocrystal-pharma-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}